US Patent Issued to Jazz Pharmaceuticals Research UK on June 3 for "Use of cannabinoids in the treatment of epilepsy" (British, American Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,356, issued on June 3, was assigned to Jazz Pharmaceuticals Research UK Ltd. (Sittingbourne, Great Britain).

"Use of cannabinoids in the treatment of epilepsy" was invented by Geoffrey Guy (Cambridge, Great Britain), Stephen Wright (Altrincham, Great Britain) and Orrin Devinsky (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Ai...